Price-file publication check · 45 CFR § 180
B · 85
This hospital's published file contains most of what § 180 requires.
●Machine-readable file published: assessment threshold met
○Gross / standard charges: below assessment threshold
●Discounted cash price: assessment threshold met
●Payer-specific negotiated rates: assessment threshold met
●Min / max negotiated charges: assessment threshold met
●Free, public, no login required: assessment threshold met
Procedures listed
6,904
Insurances with rates
3
CPT / HCPCS codes
4,764
Most expensive procedures (gross)
Q2054
$1,195,538
LISOCABTAGENE MARALEUCEL (CD8) 70000000 CELLS IV SUSP
Gross
$2,656,752
Q2054
$1,195,538
LISOCABTAGENE MARALEUCEL (CD8) 70000000 CELLS IV SUSP
Gross
$2,656,752
Q2058
$1,181,259
OBECABTAGENE AUTOLEUCEL 300 X 1,000,000 CELLS IV SUSP DAY 9
Gross
$2,625,021
Q2058
$1,181,259
OBECABTAGENE AUTOLEUCEL 100 X 1,000,000 CELLS IV SUSP 50 ML DAY 0
Gross
$2,625,021
Q2053
$1,039,508
BREXUCABTAGENE AUTOLEUCEL 200000000 CELLS IV SUSP
Gross
$2,310,018
Q2053
$1,039,508
BREXUCABTAGENE AUTOLEUCEL 200000000 CELLS IV SUSP
Gross
$2,310,018
A9543
$120,603
HC PROVSN,THER RADIORX_ZEVAL
Gross
$268,007
A9543
$120,603
HC PROVSN,THER RADIORX_ZEVAL
Gross
$268,007
J1440
$115,461
FECAL MICROBIOTA, LIVE-JSLM 150 ML RE SUSP
Gross
$256,579
J1440
$115,461
FECAL MICROBIOTA, LIVE-JSLM 150 ML RE SUSP
Gross
$256,579
A9513
$93,838
LUTETIUM LU 177 DOTATATE (LUTATHERA) 370 MBQ/ML IV SOLN
Gross
$208,529
A9513
$93,838
LUTETIUM LU 177 DOTATATE (LUTATHERA) 370 MBQ/ML IV SOLN
Gross
$208,529
J9347
$92,138
TREMELIMUMAB-ACTL 300 MG/15ML IV SOLN
Gross
$204,750
J9359
$70,500
LONCASTUXIMAB TESIRINE-LPYL 10 MG IV SOLR
Gross
$156,667
J9359
$70,500
LONCASTUXIMAB TESIRINE-LPYL 10 MG IV SOLR
Gross
$156,667
J9266
$60,334
PEGASPARGASE 750 UNIT/ML IJ SOLN
Gross
$134,076
J9266
$60,334
PEGASPARGASE 750 UNIT/ML IJ SOLN
Gross
$134,076
J1303
$55,475
RAVULIZUMAB-CWVZ 1100 MG/11ML IV SOLN
Gross
$123,277
J9229
$53,785
INOTUZUMAB OZOGAMICIN 0.9 MG IV SOLR
Gross
$119,521
J9229
$53,785
INOTUZUMAB OZOGAMICIN 0.9 MG IV SOLR
Gross
$119,521
J9274
$47,864
TEBENTAFUSP-TEBN 100 MCG/0.5ML IV SOLN
Gross
$106,365
J9274
$47,864
TEBENTAFUSP-TEBN 100 MCG/0.5ML IV SOLN
Gross
$106,365
J2350
$46,575
OCRELIZUMAB 300 MG/10ML IV SOLN
Gross
$103,501
J2350
$46,575
OCRELIZUMAB 300 MG/10ML IV SOLN
Gross
$103,501
J9350
$42,736
MOSUNETUZUMAB-AXGB 30 MG/30ML IV SOLN
Gross
$94,968
J9029
$35,438
NADOFARAGENE FIRADENOVEC-VNCG 300000000000 VP/ML IS SUSP
Gross
$78,750
J9026
$35,438
TARLATAMAB-DLLE 10 MG IV SOLR
Gross
$78,750
J9029
$35,438
NADOFARAGENE FIRADENOVEC-VNCG 300000000000 VP/ML IS SUSP
Gross
$78,750
J9298
$32,353
NIVOLUMAB-RELATLIMAB-RMBW 240-80 MG/20ML IV SOLN
Gross
$71,895
J9298
$32,353
NIVOLUMAB-RELATLIMAB-RMBW 240-80 MG/20ML IV SOLN
Gross
$71,895
C1767
$31,529
NEUROSTIMULATOR RECHAR
Gross
$70,065
J1323
$31,394
ELRANATAMAB-BCMM 76 MG/1.9ML SC SOLN
Gross
$69,765
J1323
$31,394
ELRANATAMAB-BCMM 76 MG/1.9ML SC SOLN
Gross
$69,765
J9311
$31,059
RITUXIMAB-HYALURONIDASE HUMAN 1400-23400 MG -UT/11.7ML SC SOLN
Gross
$69,020
J9311
$31,059
RITUXIMAB-HYALURONIDASE HUMAN 1400-23400 MG -UT/11.7ML SC SOLN
Gross
$69,020
J9316
$29,889
PERTUZ-TRASTUZ-HYALURON-ZZXF 80-40-2000 MG-MG-U/ML SC SOLN
Gross
$66,420
J9316
$29,889
PERTUZ-TRASTUZ-HYALURON-ZZXF 80-40-2000 MG-MG-U/ML SC SOLN
Gross
$66,420
J9042
$28,823
BRENTUXIMAB VEDOTIN 50 MG IV SOLR
Gross
$64,050
J9042
$28,823
BRENTUXIMAB VEDOTIN 50 MG IV SOLR
Gross
$64,050
C1820
$28,670
NEUROSTIMULTOR SPINAL INCEPTIV
Gross
$63,711
J9022
$28,611
ATEZOLIZUMAB 1200 MG/20ML IV SOLN
Gross
$63,581
C1787
$28,350
ELITE 7 W CONTRL PROCLAIM
Gross
$63,000
J9299
$27,939
NIVOLUMAB 240 MG/24ML IV SOLN
Gross
$62,086
J0896
$27,470
LUSPATERCEPT-AAMT 75 MG SC SOLR
Gross
$61,045
J9024
$25,808
ATEZOLIZUMAB-HYALURONIDAS-TQJS 1875-30000 MG-UT/15ML SC SOLN
Gross
$57,351
J9024
$25,808
ATEZOLIZUMAB-HYALURONIDAS-TQJS 1875-30000 MG-UT/15ML SC SOLN
Gross
$57,351
J9272
$25,419
DOSTARLIMAB-GXLY 500 MG/10ML IV SOLN
Gross
$56,488
J9272
$25,419
DOSTARLIMAB-GXLY 500 MG/10ML IV SOLN
Gross
$56,488
J3055
$24,476
TALQUETAMAB-TGVS 40 MG/ML SC SOLN
Gross
$54,390
J3055
$24,476
TALQUETAMAB-TGVS 40 MG/ML SC SOLN
Gross
$54,390
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| Q2054 | LISOCABTAGENE MARALEUCEL (CD8) 70000000 CELLS IV SUSP | $2,656,752 | $1,195,538 | $2.85 | $1,443,215 | 1 |
| Q2054 | LISOCABTAGENE MARALEUCEL (CD8) 70000000 CELLS IV SUSP | $2,656,752 | $1,195,538 | — | — | 1 |
| Q2058 | OBECABTAGENE AUTOLEUCEL 300 X 1,000,000 CELLS IV SUSP DAY 9 | $2,625,021 | $1,181,259 | $288,171 | $1,312,511 | 1 |
| Q2058 | OBECABTAGENE AUTOLEUCEL 100 X 1,000,000 CELLS IV SUSP 50 ML DAY 0 | $2,625,021 | $1,181,259 | — | — | 1 |
| Q2053 | BREXUCABTAGENE AUTOLEUCEL 200000000 CELLS IV SUSP | $2,310,018 | $1,039,508 | $2.85 | $1,304,883 | 1 |
| Q2053 | BREXUCABTAGENE AUTOLEUCEL 200000000 CELLS IV SUSP | $2,310,018 | $1,039,508 | — | — | 1 |
| A9543 | HC PROVSN,THER RADIORX_ZEVAL | $268,007 | $120,603 | $50,810 | $151,412 | 1 |
| A9543 | HC PROVSN,THER RADIORX_ZEVAL | $268,007 | $120,603 | — | — | 1 |
| J1440 | FECAL MICROBIOTA, LIVE-JSLM 150 ML RE SUSP | $256,579 | $115,461 | $48.88 | $76,974 | 1 |
| J1440 | FECAL MICROBIOTA, LIVE-JSLM 150 ML RE SUSP | $256,579 | $115,461 | — | — | 1 |
| A9513 | LUTETIUM LU 177 DOTATATE (LUTATHERA) 370 MBQ/ML IV SOLN | $208,529 | $93,838 | $225 | $733,500 | 1 |
| A9513 | LUTETIUM LU 177 DOTATATE (LUTATHERA) 370 MBQ/ML IV SOLN | $208,529 | $93,838 | — | — | 1 |
| J9347 | TREMELIMUMAB-ACTL 300 MG/15ML IV SOLN | $204,750 | $92,138 | — | — | 1 |
| J9359 | LONCASTUXIMAB TESIRINE-LPYL 10 MG IV SOLR | $156,667 | $70,500 | $156 | $47,000 | 1 |
| J9359 | LONCASTUXIMAB TESIRINE-LPYL 10 MG IV SOLR | $156,667 | $70,500 | — | — | 1 |
| J9266 | PEGASPARGASE 750 UNIT/ML IJ SOLN | $134,076 | $60,334 | $20,006 | $84,106 | 1 |
| J9266 | PEGASPARGASE 750 UNIT/ML IJ SOLN | $134,076 | $60,334 | — | — | 1 |
| J1303 | RAVULIZUMAB-CWVZ 1100 MG/11ML IV SOLN | $123,277 | $55,475 | $172 | $36,983 | 1 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG IV SOLR | $119,521 | $53,785 | $2,002 | $35,856 | 1 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG IV SOLR | $119,521 | $53,785 | — | — | 1 |
| J9274 | TEBENTAFUSP-TEBN 100 MCG/0.5ML IV SOLN | $106,365 | $47,864 | $162 | $31,910 | 1 |
| J9274 | TEBENTAFUSP-TEBN 100 MCG/0.5ML IV SOLN | $106,365 | $47,864 | — | — | 1 |
| J2350 | OCRELIZUMAB 300 MG/10ML IV SOLN | $103,501 | $46,575 | $46.37 | $31,050 | 1 |
| J2350 | OCRELIZUMAB 300 MG/10ML IV SOLN | $103,501 | $46,575 | — | — | 1 |
| J9350 | MOSUNETUZUMAB-AXGB 30 MG/30ML IV SOLN | $94,968 | $42,736 | — | — | 1 |
| J9029 | NADOFARAGENE FIRADENOVEC-VNCG 300000000000 VP/ML IS SUSP | $78,750 | $35,438 | $9,930 | $78,750 | 1 |
| J9026 | TARLATAMAB-DLLE 10 MG IV SOLR | $78,750 | $35,438 | $978 | $23,625 | 1 |
| J9029 | NADOFARAGENE FIRADENOVEC-VNCG 300000000000 VP/ML IS SUSP | $78,750 | $35,438 | — | — | 1 |
| J9298 | NIVOLUMAB-RELATLIMAB-RMBW 240-80 MG/20ML IV SOLN | $71,895 | $32,353 | $145 | $21,569 | 1 |
| J9298 | NIVOLUMAB-RELATLIMAB-RMBW 240-80 MG/20ML IV SOLN | $71,895 | $32,353 | — | — | 1 |
| C1767 | NEUROSTIMULATOR RECHAR | $70,065 | $31,529 | — | — | 1 |
| J1323 | ELRANATAMAB-BCMM 76 MG/1.9ML SC SOLN | $69,765 | $31,394 | $177 | $20,929 | 1 |
| J1323 | ELRANATAMAB-BCMM 76 MG/1.9ML SC SOLN | $69,765 | $31,394 | — | — | 1 |
| J9311 | RITUXIMAB-HYALURONIDASE HUMAN 1400-23400 MG -UT/11.7ML SC SOLN | $69,020 | $31,059 | $29.02 | $20,706 | 1 |
| J9311 | RITUXIMAB-HYALURONIDASE HUMAN 1400-23400 MG -UT/11.7ML SC SOLN | $69,020 | $31,059 | — | — | 1 |
| J9316 | PERTUZ-TRASTUZ-HYALURON-ZZXF 80-40-2000 MG-MG-U/ML SC SOLN | $66,420 | $29,889 | $52.03 | $19,926 | 1 |
| J9316 | PERTUZ-TRASTUZ-HYALURON-ZZXF 80-40-2000 MG-MG-U/ML SC SOLN | $66,420 | $29,889 | — | — | 1 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG IV SOLR | $64,050 | $28,823 | $179 | $19,215 | 1 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG IV SOLR | $64,050 | $28,823 | — | — | 1 |
| C1820 | NEUROSTIMULTOR SPINAL INCEPTIV | $63,711 | $28,670 | — | — | 1 |
| J9022 | ATEZOLIZUMAB 1200 MG/20ML IV SOLN | $63,581 | $28,611 | $65.97 | $19,074 | 1 |
| C1787 | ELITE 7 W CONTRL PROCLAIM | $63,000 | $28,350 | — | — | 1 |
| J9299 | NIVOLUMAB 240 MG/24ML IV SOLN | $62,086 | $27,939 | $24.12 | $18,626 | 1 |
| J0896 | LUSPATERCEPT-AAMT 75 MG SC SOLR | $61,045 | $27,470 | — | — | 1 |
| J9024 | ATEZOLIZUMAB-HYALURONIDAS-TQJS 1875-30000 MG-UT/15ML SC SOLN | $57,351 | $25,808 | $23.96 | $28,676 | 1 |
| J9024 | ATEZOLIZUMAB-HYALURONIDAS-TQJS 1875-30000 MG-UT/15ML SC SOLN | $57,351 | $25,808 | — | — | 1 |
| J9272 | DOSTARLIMAB-GXLY 500 MG/10ML IV SOLN | $56,488 | $25,419 | $181 | $16,946 | 1 |
| J9272 | DOSTARLIMAB-GXLY 500 MG/10ML IV SOLN | $56,488 | $25,419 | — | — | 1 |
| J3055 | TALQUETAMAB-TGVS 40 MG/ML SC SOLN | $54,390 | $24,476 | $67.9 | $16,317 | 1 |
| J3055 | TALQUETAMAB-TGVS 40 MG/ML SC SOLN | $54,390 | $24,476 | — | — | 1 |
Showing top 50 of 6,904 priced procedures, sorted by gross charge.
Data straight from this hospital's own published price file (45 CFR § 180). The grade scores how completely the file contains the six required data elements. It is a check of the file — not a CMS compliance ruling, and not a measure of quality of care.